Literature DB >> 33796178

[Malaria infection during pregnancy in Niamey, Niger].

Zara Maman Oumarou1, Mahaman Moustapha Lamine2,3, Tahirou Issaka4, Kamayé Moumouni4, Ibrahim Alkassoum5, Daou Maman4, Mahamadou Doutchi6, Soumana Alido4, Ibrahim Maman Laminou3.   

Abstract

INTRODUCTION: malaria during pregnancy is a major public health problem in Africa. It can have serious consequences for mother, fetus and newborn. It is associated with high maternal and infant mortality rate. The purpose of our study was to determine the prevalence of plasmodium infection in pregnant women, describe their clinical signs and potential complications, analyze associated factors, and propose preventive measures.
METHODS: we conducted a cross-sectional study at the Issaka Gazobi Maternity Ward (MIG), Niamey, from 1 June to 30 November 2017. Diagnosis was based on microscopic examination.
RESULTS: two hundred and forty-nine (249) women were included in this study. The prevalence of plasmodium infection was 36.5% (IC95%; [30.6; 42.9]). Mean parasite density was 177 P/μl (SD: 121; [40; 800]). All infections were due to P. falciparum. Seventy-three point six percent (67/91) of infected women were asymptomatic. Only 26.4% (24/91) of them had uncomplicated malaria; 9.6% (6/91) had miscarriage; 38.4% of newborns were low birthweight; 26.51% (66/249) developed congenital malaria. Mortality rate was 1.1% (1/ 91). Intermittent preventive treatment (IPT) significantly protected patients against gestational malaria (p=0.01).
CONCLUSION: in Niger, P. falciparum infection very commonly affects pregnant women. It is most often asymptomatic but it can lead to uncomplicated or even severe malaria. Main consequences include abortion, low birth weight, intrauterine growth retardation, congenital malaria and maternal death. IPT and the use of long-lasting insecticide-treated mosquito nets (LLINs) can prevent infection. Copyright: Zara Maman Oumarou et al.

Entities:  

Keywords:  Malaria; Niger; clinical signs; pregnant women; risk factors

Mesh:

Year:  2020        PMID: 33796178      PMCID: PMC7992404          DOI: 10.11604/pamj.2020.37.365.20034

Source DB:  PubMed          Journal:  Pan Afr Med J


  17 in total

1.  [Study of factors favouring the occurrence of Plasmodium falciparum in pregnant women in the health district of Bogodogo].

Authors:  C M R Ouédraogo; G Nébié; L Sawadogo; G Rouamba; A Ouédraogo; J Lankoandé
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2011-04-22

2.  Factors Influencing Prevention and Control of Malaria among Pregnant Women Resident in Urban Slums, Southern Ghana.

Authors:  Mavis Dako-Gyeke; Humphrey M Kofie
Journal:  Afr J Reprod Health       Date:  2015-03

3.  Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.

Authors:  Eric Bertrand Fokam; Leonard Ngimuh; Judith K Anchang-Kimbi; Samuel Wanji
Journal:  Malar J       Date:  2016-03-17       Impact factor: 2.979

Review 4.  Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review.

Authors:  Makoto Saito; Mary Ellen Gilder; François Nosten; Philippe J Guérin; Rose McGready
Journal:  Malar J       Date:  2017-12-18       Impact factor: 2.979

5.  Asymptomatic malaria correlates with anaemia in pregnant women at Ouagadougou, Burkina Faso.

Authors:  Zoenabo Douamba; Cyrille Bisseye; Florencia W Djigma; Tegwinde R Compaoré; Valérie Jean Telesphore Bazie; Virginio Pietra; Jean-Baptiste Nikiema; Jacques Simpore
Journal:  J Biomed Biotechnol       Date:  2012-11-11

6.  Prevalence and risk factors associated with malaria infection among pregnant women in a semi-urban community of north-western Nigeria.

Authors:  Sani Abdullahi Fana; Mohammed Danladi Abubakar Bunza; Sule Aliyu Anka; Asiya Umar Imam; Shehu Usman Nataala
Journal:  Infect Dis Poverty       Date:  2015-04-24       Impact factor: 4.520

7.  Population-based prevalence of malaria among pregnant women in Enugu State, Nigeria: the Healthy Beginning Initiative.

Authors:  Jayleen K L Gunn; John E Ehiri; Elizabeth T Jacobs; Kacey C Ernst; Sydney Pettygrove; Lindsay N Kohler; Steven D Haenchen; Michael C Obiefune; Chinenye O Ezeanolue; Amaka G Ogidi; Echezona E Ezeanolue
Journal:  Malar J       Date:  2015-11-05       Impact factor: 2.979

8.  Clinical signs and symptoms cannot reliably predict Plasmodium falciparum malaria infection in pregnant women living in an area of high seasonal transmission.

Authors:  Marc C Tahita; Halidou Tinto; Joris Menten; Jean-Bosco Ouedraogo; Robert T Guiguemde; Jean Pierre van Geertruyden; Annette Erhart; Umberto D'Alessandro
Journal:  Malar J       Date:  2013-12-27       Impact factor: 2.979

9.  Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.

Authors:  Rebecca F Grais; Ibrahim M Laminou; Lynda Woi-Messe; Rockyath Makarimi; Seidou H Bouriema; Celine Langendorf; Alfred Amambua-Ngwa; Umberto D'Alessandro; Philippe J Guérin; Thierry Fandeur; Carol H Sibley
Journal:  Malar J       Date:  2018-02-27       Impact factor: 2.979

10.  Prevention and treatment of malaria in pregnancy: what do pregnant women and health care workers in East India know and do about it?

Authors:  Lora Sabin; Evan M S Hecht; Mohamad I Brooks; Mrigendra P Singh; Kojo Yeboah-Antwi; Abanish Rizal; Blair J Wylie; Philip A Bondzie; Matthew Banos; Jordan Tuchman; Neeru Singh; Davidson H Hamer
Journal:  Malar J       Date:  2018-05-18       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.